PERME is a deep-tech digital health platform that develops disruptive innovation in home testing with a Novel IP. PERME converts biological samples to digital information in real-time with an affordable device no labs need. With a market potential surpassing $500 billion, its innovative approach is guided by experts in nanotechnology, MEMS (Micro-Electro-Mechanical Systems), longevity, genetics, RF engineering, bioinformatics, and tech entrepreneurs. The company's software initially converts biological data into digital output resulting in health recommendations and telehealth consultations.. Applying advanced data analytics and AI/ML on the big data PerMe is collecting, will be the heart of healthcare innovation, understanding complex diseases and discovering new medicines.